0.1700
0.0000
(0.00%)
At close: 3:30:05 PM EDT
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Expense
26,436.3200
31,663.7420
40,501.5930
24,753.7610
6,936.5070
Operating Income
-26,436.3200
-31,663.7420
-40,501.5930
-24,753.7610
-6,936.5070
Net Non Operating Interest Income Expense
-565.8650
-198.4670
1,468.1470
459.2830
12.1840
Other Income Expense
-1,128.7680
-322.9260
35.9260
-126.0580
-41.2160
Pretax Income
-28,130.9530
-32,185.1350
-38,997.5200
-24,420.5360
-6,965.5390
Tax Provision
13.4000
7
--
--
--
Net Income Common Stockholders
-28,144.3530
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Diluted NI Available to Com Stockholders
-28,144.3530
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Basic EPS
-0.09
--
-0.13
-0.09
-0.03
Diluted EPS
-0.09
--
-0.13
-0.09
-0.03
Basic Average Shares
312,989.8420
--
303,332.6860
273,593.1430
245,522.7700
Diluted Average Shares
312,989.8420
--
303,332.6860
273,593.1430
245,522.7700
Total Expenses
26,436.3200
31,663.7420
40,501.5930
24,753.7610
6,936.5070
Net Income from Continuing & Discontinued Operation
-28,144.3530
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Normalized Income
-27,467.0922
-31,917.6479
-39,033.4460
-24,294.4780
-6,924.3230
Interest Income
245.5130
388.3910
1,500.2220
577.2850
70.5520
Interest Expense
811.3780
586.8580
32.0750
118.0020
58.3680
Net Interest Income
-565.8650
-198.4670
1,468.1470
459.2830
12.1840
EBIT
-27,319.5750
-31,598.2770
-38,965.4450
-24,302.5340
-6,907.1710
EBITDA
-26,835.8830
-31,057.9970
-38,519.8940
-23,862.5360
-6,639.9670
Reconciled Depreciation
483.6920
540.2800
445.5510
439.9980
267.2040
Net Income from Continuing Operation Net Minority Interest
-28,144.3530
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Total Unusual Items Excluding Goodwill
-1,128.7680
-322.9260
35.9260
-126.0580
-41.2160
Total Unusual Items
-1,128.7680
-322.9260
35.9260
-126.0580
-41.2160
Normalized EBITDA
-25,707.1150
-30,735.0710
-38,555.8200
-23,736.4780
-6,598.7510
Tax Rate for Calcs
0.0004
0.0002
--
--
--
Tax Effect of Unusual Items
-451.5072
-48.4389
--
--
--
10/31/2021 - 4/29/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SVA Sinovac Biotech Ltd.
6.47
0.00%
BETR.CN BetterLife Pharma Inc.
0.0850
0.00%
NK9.F Neuren Pharmaceuticals Limited
4.5400
-7.35%
RKV.V Rakovina Therapeutics Inc.
0.0550
-8.33%
WF6.MU MindBio Therapeutics Corp
0.0084
0.00%
CHGX.CN ChitogenX Inc.
0.0100
+100.00%
ANL Adlai Nortye Ltd.
1.9400
+7.18%
VCNX Vaccinex, Inc.
0.4800
+32.49%
QPT.V Quest PharmaTech Inc.
0.0550
0.00%
ONCY Oncolytics Biotech Inc.
0.6229
+26.43%